X. Zhang et al.
122.21, 41.05, 14.99 ppm; 31P NMR (162 MHz, CDCl3): d=141.00 (d, J=
59.1 Hz), À13.48 ppm (d, J=59.1 Hz); HRMS (ESI): m/z: calcd for
C54H40NO2P2 ([M+H+]): 796.2534; found: 796.2536.
96% ee for allyl cyanide were achieved, which represents
the best results to date. The relationship between the sub-
stituent and the enantioselectivity of the ligands was de-
duced, which was successfully rationalized by Herrmannꢁs
theoretical model by CAChe MM2 calculations. Further
studies aimed at a better understanding of the origin of the
selectivity of phosphine–phospharamidite ligands and their
application in other metal-catalyzed transformations are in
progress and will be reported in due course.
AHCTUNGTRENNUNG
(S,R)-9c: Yield=42%; white solid; [a]2D0 =+32.5 (c=0.3, CHCl3);
1H NMR (500 MHz, CDCl3): d=8.17 (d, J=8.5 Hz, 1H), 8.15 (d, J=
8.0 Hz, 1H), 7.97 (d, J=8.0 Hz, 1H), 7.92 (d, J=8.0 Hz, 1H), 7.74–7.60
(m, 5H), 7.43–7.01 (m, 23H), 6.87–6.83 (m, 2H), 6.79–6.75 (m, 2H),
6.45–6.42 (m, 1H), 6.24 (d, J=8.5 Hz, 1H), 5.93 (d, J=8.5 Hz, 1H), 3.82
(d, J=14.5 Hz, 1H), 3.21 (d, J=14.5 Hz, 1H); 13C NMR (125 MHz,
CDCl3): d=150.09, 150.05, 149.84, 142.04, 141.91, 138.75, 128.24, 127.92,
137.81, 135.61, 135.42, 133.97, 133.56, 133.43, 132.01, 131.81, 131.75,
131.61, 130.72, 130.50, 130.35, 129.87, 129.81, 128.83, 128.74, 128.56,
128.48, 128.40, 128.37, 128.33, 128.21, 128.11, 128.04, 127.89, 127.84,
127.79, 127.40, 127.23, 127.20, 127.04, 126.88, 126.71, 126.08, 126.03,
125.32, 124.88, 124.63, 122.78, 122.55, 122.10, 51.32 ppm; 31P NMR
(202 MHz, CDCl3): d=138.41 (d, J=78.6 Hz), À11.86 ppm (d, J=
78.6 Hz); HRMS (ESI): m/z: calcd for C59H42NO2P2 ([M+H+]): 858.2691;
found: 858.2692.
Experimental Section
General methods: All reactions and manipulations that were sensitive to
moisture or air were performed in a nitrogen-filled glovebox or using
standard Schlenk techniques, unless otherwise noted. Solvents were dried
with standard procedures and degassed with N2. Column chromatography
was performed by using 200–400 mesh silica gel supplied by Natland In-
ternational Corp. Thin-layer chromatography (TLC) was performed on
EM reagents 0.25 mm silica 60-F plates. 1H, 13C, and 31P NMR spectra
were recorded in CDCl3 or CD2Cl2 on a Bruker Avance 400 MHz spec-
trometer or a Varian Mercury 500 MHz FT-NMR spectrometer. Optical
rotation was obtained on a Perkin–Elmer 341 MC polarimeter. HRMS
were recorded on a Thermo LTQ Orbitrap hybrid mass spectrometer.
GC analysis was carried out on Hewlett–Packard 7890 gas chromato-
graph using chiral capillary columns. Compounds (S)-7a–(S)-7c,[12] (R)-
7b,[10] 8a,[9b] 8d,[9d] 8e,[18] and 8 f[18] were synthesized according to the cor-
responding literature procedures.
A
1H NMR (400 MHz, CD2Cl2): d=8.04–7.96 (m, 3H), 7.86–7.79 (m, 3H),
7.72 (d, J=8.0 Hz, 1H), 7.68 (d, J=8.4 Hz, 1H), 7.53–7.45 (m, 2H), 7.39–
7.28 (m, 5H), 7.26–7.05 (m, 11H), 6.96–6.93 (m, 2H), 6.86–6.81 (m, 2H),
6.61–6.57 (m, 1H), 6.33 (d, J=8.4 Hz, 1H), 2.94–2.83 (m, 1H), 2.58 (s,
3H), 2.50–2.45 (m, 1H), 1.66 (s, 3H), 0.70 ppm (t, J=7.2 Hz, 3H);
13C NMR (100 MHz, CD2Cl2): d=150.19, 150.12, 149.84, 142.23, 141.90,
138.93, 138.61, 138.57, 138.34, 137.72, 135.86, 135.34, 135.12, 134.41,
134.11, 133.94, 133.75, 133.74, 132.18, 132.01, 131.75, 131.68, 131.23,
131.07, 130.80, 130.06, 129.49, 129.09, 128.91, 128.58, 128.48, 128.29,
128.21, 127.93, 127.64, 127.29, 127.11, 127.02, 126.66, 125.80, 125.56,
125.32, 125.23, 125.07, 124.73, 121.81, 41.54, 17.66, 14.76 ppm; 31P NMR
(162 MHz, CD2Cl2): d=139.00 (d, J=61.6 Hz), À14.60 ppm (d, J=
61.6 Hz); HRMS (ESI): m/z: calcd for C56H44NO2P2 ([M+H+]): 824.2847;
found: 824.2843.
A typical procedure for the preparation of ligand 9: The synthesis of 9b
was reported in previous work.[10] Ligands 9a, 9c, and 9d were prepared
following a similar procedure. A typical procedure for (S,R)-9a is as fol-
lows: nBuLi (1.2 mmol, 0.48 mL of 2.5m hexane solution) was added
dropwise to a solution of (S)-7a (480 mg, 1.0 mmol) in anhydrous THF
(10 mL) at À78 8C under an N2 atmosphere. The reaction mixture turned
deep red and was stirred for 4 h at that temperature. Then (R)-8a
(454 mg, 1.3 mmol) in THF (6 mL) was added dropwise. After addition,
the reaction mixture was allowed to warm to room temperature and
stirred overnight. The volatiles were removed under vacuum. CH2Cl2
(5 mL) was added to the residue, and the mixture was filtered to remove
the inorganic salt. The filtrate was concentrated and subjected to flash
chromatography on silica gel (eluted with hexane/EtOAc/NEt3 100:10:1)
to afford pure ligand (S,R)-9a (257 mg) as a white solid in 33% yield.
[a]2D0 =À32.6 (c=0.3, CHCl3); 1H NMR (500 MHz, CDCl3): d=8.04–8.01
(m, 3H), 7.85 (t, J=8.5 Hz, 2H), 7.78 (d, J=8.5 Hz, 2H), 7.68 (d, J=
9.0 Hz, 1H), 7.61–7.57 (m, 2H), 7.38–6.93 (m, 21H), 6.59 (dd, J=8.5,
7.0 Hz, 1H), 6.49 (d, J=8.5 Hz, 1H), 6.31 (d, J=8.5 Hz, 1H), 2.45 ppm
(s, 3H); 13C NMR (125 MHz, CDCl3): d=150.45, 150.41, 149.61, 142.76,
142.49, 138.60, 138.49, 137.88, 137.79, 136.63, 135.25, 135.07, 134.08,
133.16, 133.03, 132.65, 131.61, 131.50, 130.73, 130.28, 129.94, 129.87,
128.84, 128.48, 128.31, 128.28, 128.20, 128.02, 127.75, 127.56, 127.42,
127.24, 127.16, 126.99, 126.53, 126.09, 125.69, 125.35, 124.86, 124.64,
124.12, 124.08, 122.28, 122.20, 35.67, 35.64 ppm; 31P NMR (202 MHz,
CDCl3): d=141.09 (d, J=45.2 Hz), À12.67 ppm (d, J=45.2 Hz); HRMS
(ESI): m/z: calcd for C53H38NO2P2 ([M+H+]): 782.2578; found: 782.2374.
AHCTUNGTRENNUNG
(R,S)-9e: Yield=38%; white solid; [a]2D0 =+91.7 (c=0.5, CHCl3);
1H NMR (400 MHz, CDCl3): d=7.98 (d, J=8.8 Hz, 1H), 7.93 (d, J=
8.4 Hz, 1H), 7.89 (d, J=8.4 Hz, 1H), 7.83 (d, J=8.0 Hz, 1H), 7.72 (d, J=
8.8 Hz, 1H), 7.63 (dd, J=8.4, 2.4 Hz, 1H), 7.50–7.46 (m, 1H), 7.24–7.12
(m, 6H), 7.06–6.87 (m, 9H), 6.65 (t, J=8.0 Hz, 1H), 3.58–3.50 (m, 1H),
2.80–2.73 (m, 1H), 2.23 (s, 3H), 2.20 (s, 3H), 1.78 (s, 3H), 1.76 (s, 3H),
1.34 (s, 9H), 0.81 (t, J=7.2 Hz, 3H), 0.74 ppm (s, 9H); 13C NMR
(100 MHz, CDCl3): d=148.95, 148.84, 147.74, 147.69, 142.72, 142.39,
138.85, 138.69, 138.46, 137.80, 137.77, 136.43, 135.12, 134.89, 134.57,
134.31, 134.05, 133.68, 133.29, 133.23, 133.13, 133.07, 131.80, 131.73,
131.25, 131.05, 130.76, 129.55, 129.38, 128.13, 128.06, 128.03, 127.72,
127.64, 127.46, 127.25, 127.20, 126.64, 126.55, 125.75, 125.15, 124.70, 40.05,
34.63, 34.07, 31.29, 31.26, 30.05, 20.19, 16.80, 16.31, 13.06 ppm; 31P NMR
(162 MHz, CDCl3): d=130.50 (d, J=97.2 Hz), À14.89 ppm (d, J=
97.2 Hz); HRMS (ESI): m/z: calcd for C58H60NO2P2 ([M+H+]):
864.4099; found: 864.4105.
(R)-9 f: Yield=52%; white solid; [a]2D0 =+40.7 (c=0.5, CHCl3);
1H NMR (400 MHz, CDCl3) d: 7.91 (d, J=7.2 Hz, 1H), 7.83 (d, J=
8.4 Hz, 2H), 7.73 (d, J=8.4 Hz, 2H), 7.50 (dd, J=7.2, 2.8 Hz, 1H), 7.39
(t, J=7.2 Hz, 1H) 7.24–7.00 (m, 11H), 6.97-6.93 (m, 4H), 6.85 (t, J=
7.6 Hz, 2H), 6.51–6.47 (m, 1H), 6.27 (d, J=8.4 Hz, 1H), 3.39–3.32 (m,
1H), 3.06–2.97 (m, 1H), 1.24 (s, 9H), 1.23 (s, 9H), 1.04–0.98 (m, 18H),
0.82 ppm (t, J=6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=147.50,
147.40, 146.82, 146.77, 144.32, 144.26, 143.68, 143.63, 138.82, 138.49,
137.93, 137.77, 136.99, 136.85, 133.97, 133.74, 133.48, 133.42, 133.12,
132.29, 132.22, 132.02, 131.97, 131.85, 131.80, 131.48, 130.24, 129.84,
129.73, 128.01, 127.79, 127.24, 127.05, 126.96, 126.87, 126.79, 126.68,
126.63, 126.39, 126.19, 126.14, 125.95, 125.77, 125.40, 125.04, 124.28,
124.14, 123.98, 122.77, 122.74, 37.77, 34.09, 33.67, 33.53, 33.45, 30.53,
30.49, 29.73, 29.34, 20.43 ppm; 31P NMR (162 MHz, CDCl3): d=136.29
(br), À14.93 ppm (d, J=62.4 Hz); HRMS (ESI): m/z: calcd for
C62H68NO2P2 ([M+H+]): 920.4725; found: 920.4749.
Ligands 9b–f were synthesized in moderate yields following the above
procedure. Their characterization data are summarized as follows.
A
1H NMR (400 MHz, CDCl3): d=8.07–7.98 (m, 3H), 7.90 (t, J=7.3 Hz,
2H), 7.78 (d, J=8.2 Hz, 2H), 7.64–7.57 (m, 4H), 7.38–6.99 (m, 16H),
6.96 (t, J=6.8 Hz, 2H), 6.85 (t, J=7.1 Hz, 2H), 6.55 (t, J=7.7 Hz, 1H),
6.38–6.29 (m, 2H), 2.75–2.67 (m, 1H), 2.37–2.29 (m, 1H), 0.65 ppm (t,
J=7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=150.29, 150.22, 149.94,
142.34, 141.95, 138.57, 138.36, 138.27, 138.20, 135.44, 135.14, 134.10,
133.57, 133.36, 131.68, 130.50, 129.88, 129.11, 128.66, 128.59, 128.55,
128.49, 128.46, 128.42, 128.30, 128.12, 127.56, 127.19, 127.12, 127.03,
126.66, 126.29, 126.17, 125.71, 125.53, 125.06, 124.76, 122.49, 122.24,
General procedure for asymmetric hydroformylation: In
filled with nitrogen, to a 2 mL vial equipped with a magnetic bar was
added ligand 9 (0.004 mmol), [Rh(acac)(CO)2] (0.001 mmol in 0.10 mL
a glovebox
AHCTUNGTRENNUNG
876
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 871 – 877